Showing results (101-110 of 656) with videos related to
Sort By:
Pageof 66
The Lancet. Microbe|January 14, 2024
Antibiotic resistance determination using Enterococcus faecium whole-genome sequences: a diagnostic accuracy study using genotypic and phenotypic dataFrancesc Coll, Theodore Gouliouris, Beth Blane, et al.The Lancet. Microbe|December 2, 2023
Approaches and challenges to inferring the geographical source of infectious disease outbreaks using genomic dataZhiyuan Chen, Philippe Lemey, Hongjie YuThe Lancet. Microbe|December 9, 2023
Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic reviewPierre R Smeesters, Gabrielle de Crombrugghe, Shu Ki Tsoi, et al.The Lancet. Microbe|December 7, 2023
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysisAna María García-Marín, Irving Cancino-Muñoz, Manuela Torres-Puente, et al.The Lancet. Microbe|March 10, 2024
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X frameworkThe Lancet. Microbe|March 11, 2024
The global distribution and the risk prediction of relapsing fever group Borrelia: a data review with modelling analysisTian Tang, Ying Zhu, Yuan-Yuan Zhang, et al.The Lancet. Microbe|January 29, 2024
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysisZoe Raglow, Diya Surie, James D Chappell, et al.The Lancet. Microbe|May 11, 2024
Effect of human H3N2 influenza virus reassortment on influenza incidence and severity during the 2017-18 influenza season in the USA: a retrospective observational genomic analysisHsuan Liu, Kathryn Shaw-Saliba, Jason Westerbeck, et al.The Lancet. Microbe|May 18, 2024
Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional studyValentin Joste, Romain Coppée, Justine Bailly, et al.The Lancet. Microbe|May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trialBrittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.Pageof 66